Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NRX 195183 in relapsed or refractory APL
NCT00675870Phase 2Unknown
- Sponsor
- Nurx
- Start
- Apr 2008
- Primary completion
- Apr 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of irx-5183 in acute promyelocytic leukemia (APL), sponsored by Nurx. Status: unknown.
02
Drugs
irx-5183
03
Conditions
acute promyelocytic leukemia (APL)
Beyond the preview
Go deeper on NCT00675870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00675870.